Drug Database
NI

nitroglycerin (nitroglycerin, I2R / NitroMist)

✓ Approved

Seelos Therapeutics, Inc. · 小分子 · 小分子

什么是 nitroglycerin?

nitroglycerin 是一种小分子,由Seelos Therapeutics, Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)、Sublingual (SL)/Oral Transmucosal。

药物档案

商品名nitroglycerin, I2R, NitroMist
公司Seelos Therapeutics, Inc.
药物类别小分子
给药途径Oral (PO), Sublingual (SL)/Oral Transmucosal
状态Approved

治疗适应症

nitroglycerin 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Cardiac disordersAngina pectorisPreclinical

相关研究文献

PubMedBMC medical imaging2026-11-19

Body size-normalized quantitative assessment of coronary lumen volume following sublingual nitroglycerin at CT angiography.

Balaban Ismail I, Alicioglu Banu B

Sublingual nitroglycerin is widely used before coronary computed tomography angiography to induce coronary vasodilation and enhance visualization of distal coronary segments and small side branches. The aim of the study was to assess the effect of sublingual nitroglycerin on whole-vessel coronary lumen volume in coronary computed tomography angiography and to determine whether this response varies after normalization for body size parameters. This single-center retrospective comparative study included patients who underwent coronary computed tomography angiography using a 128-detector computed tomography scanner. Patients were classified according to pre-scan nitroglycerin administration. In the nitroglycerin group, 400 µg of sublingual nitroglycerin was administered 3-5 minutes before image acquisition. Age-matched patients who did not receive nitroglycerin served as controls. Coronary lumen volumes were calculated semi-automatically using dedicated software and normalized to body mass index and body surface area. The number of coronary side branches and intraluminal contrast enhancement in proximal and distal segments were also assessed. A total of 194 patients were included. Compared with controls, the nitroglycerin group demonstrated significantly larger median coronary lumen volumes (left anterior descending artery: 519 vs 429 mm3, right coronary artery: 634 vs 468 mm3, left circumflex artery: 381 vs 249 mm3), together with higher body size-normalized lumen volumes (all p ≤ 0.009). The number of septal, diagonal, and obtuse marginal branches was also significantly higher in the nitroglycerin group (p < 0.001). The proximal-to-distal contrast enhancement ratios of the left anterior descending and left circumflex arteries were significantly lower in the nitroglycerin group (p < 0.001). Sublingual nitroglycerin significantly increases whole-vessel coronary lumen volume on coronary computed tomography angiography. This quantitative volumetric effect persists after body size normalization and may improve coronary visualization in patients with larger body habitus.

PMID 43052801
阅读全文 →
PubMedJournal of central nervous system disease2026-11-18

Sex-Specific Circadian Dysregulation in the Choroid Plexus of a Nitroglycerin Rat Model of Chronic Migraine: An RNA-Seq Analysis.

Woldeamanuel Yohannes Woubishet YW, Xia Chenchen C, Ding Sam S, Fonteh Alfred A et al.

Migraine patients show choroid plexus (CP) changes, impairing the blood-CSF barrier. The CP regulates circadian rhythms, but links between CP circadian genes and migraine are unexplored. This study examined changes in the CP circadian gene transcriptome in a chronic migraine rat model compared with controls to identify migraine-related pathways. Chronic migraine model: Sprague-Dawley rats (3 females, 3 males) received nitroglycerin (NTG) every other day for 9 days; controls (3 females, 3 males) got saline. CP from the 4th ventricle was collected 2 hours after the final injection for RNA-seq. Migraine Behavior: Von Frey hair tests on days 1, 5, and 9, pre- and 2 hours post-NTG/saline injection, assessed basal and NTG-induced pain thresholds. RNA-seq & Analysis: Differentially expressed genes (p < 0.05, fold change > 1) were identified. GO, KEGG, and Reactome enrichment analyses were performed to assess changes in circadian gene expression. The NTG group showed reduced basal and NTG-induced pain thresholds on days 1, 5, and 9. Females had a greater number of upregulated genes (MT2A, SLC7A11); males had upregulated ZBTB16 and S100A8. SLC7A11, SCG2, and GRIA1 showed inverse regulation (up in females, down in males). Circadian gene expression altered: 10 genes upregulated (e.g., SERPINE1, MAPK9, ATF4), 13 downregulated (e.g., PER2, DBP, EZH2). Sex-specific differences: females (FBXL12, GPR157), males (NKX2-1, ATF4, CLOCK). GO/KEGG analyses revealed significant enrichment of circadian rhythm-related pathways, insulin resistance, and inflammatory response processes, with sex-specific differences: females showed enrichment in HIF-1 signaling and hemoglobin-related pathways, while males exhibited enrichment in arachidonic acid and leukotriene production. CP transcriptomics in the rat migraine model revealed sex-specific gene regulation, with females upregulating antioxidant genes (MT2A, SLC7A11) and males upregulating inflammatory factors (ZBTB16, S100A8), alongside circadian disruption (e.g., SERPINE1 upregulated, PER2 downregulated). Pathway analyses indicate enriched circadian rhythms, HIF-1 signaling (females), inflammatory processes (males), lipid metabolism (PPARα), and heme signaling, highlighting sex-specific and circadian targets for migraine therapy.

PMID 43048019
阅读全文 →
PubMedLangenbeck's archives of surgery2026-11-17

Towards alpha-blockade-free surgery for pheochromocytoma and paraganglioma: experience from a newly established adrenal center.

Knyazeva P P, Meyer A A, Thal S C SC, Bachmann T T et al.

Pheochromocytomas are rare catecholamine-secreting tumors for which surgical resection is the definitive treatment. Traditionally, preoperative alpha-adrenergic blockade is strictly recommended. However, recent evidence has questioned its necessity. In this study, we report our experience with pheochromocytoma surgery at a newly established adrenal center without prior specialization in adrenal surgery. From May 2022 to May 2026, 18 patients (14 female, 4 male; median age 63.1 years, interquartile range (IQR) 46.2-70.1) with catecholamine-producing tumors (15 pheochromocytomas and 3 paragangliomas) underwent surgical resection in our institution. Seventeen patients did not receive any preoperative alpha-adrenergic blockade, whereas one patient underwent surgery while already receiving phenoxybenzamine therapy initiated by the referral physician prior to admission. Intraoperative management included general anaesthesia, central venous access, and invasive arterial blood pressure monitoring. Urapidil and/or nitroglycerin were used as the primary antihypertensive agents. Data were prospectively collected and retrospectively analyzed, including patient demographics, preoperative metanephrine and normetanephrine secretion, intraoperative treatment of hypertension and hypotension, and postoperative outcomes. The median operative time was 49.5 min (IQR, 30-90). Sixteen procedures were performed minimally invasively (15 retroperitoneoscopic and one laparoscopic), and two by open approach. Partial adrenalectomy was performed in seven cases. Histology confirmed chromaffin cell tumors in all cases, with a median tumor size of 4.0 cm (IQR 3.15-5.15). Median peak intraoperative systolic blood pressure was 195 mmHg (IQR, 166-200). For intraoperative blood pressure control, urapidil was administered to 4 patients (22.2%), nitroglycerin to 3 (16.7%), and both agents to 3 (16.7%). The remaining 8 patients (44.4%), did not require pharmacological treatment. Ten patients (55.6%) had a maximum intraoperative noradrenaline requirement < 0.2 µg/kg/min, 5 (27.8%) required intermediate doses of 0.2-0.4 µg/kg/min, and 3 (16.7%) required high doses > 0.4 µg/kg/min. Median postoperative hospital stay was 2 days (IQR, 2-3). Two patients developed transient atrial fibrillation. No major complications or mortality occurred. Our results support the feasibility of alpha-blockade-free surgery for pheochromocytoma, even in centers with limited prior experience in pheochromocytoma surgery. Education of the anaesthesiology team, structured perioperative protocols, and close interdisciplinary collaboration appear to be important for ensuring safe perioperative management.

PMID 43043502
阅读全文 →
PubMedJournal of cardiothoracic and vascular anesthesia2026-11-15

High-Dose Nitroglycerin for Prevention of Coronary Artery Spasm During Arrhythmia Ablation.

Le Christina C, Saksa Dane D, Patel Komal K, Harvey Reed R et al.

PMID 43034096
阅读全文 →
PubMedPolymers2026-11-14

A Self-Healing Adhesive Exploiting Hydrogen-Bonding Interactions and Aromatic Disulfide Units in Energetic Composites.

Zhao Huan H, Song Xiuduo X, Yang Weilu W, Hu Yiwen Y et al.

Energetic composites with high solid content are prone to microcracking and interfacial debonding, which can compromise mechanical integrity and service reliability. To address these long-standing durability challenges, herein, a self-healing polyurethane with hydrogen bonds and disulfide bonds (PUHD) was designed by integrating hydrogen-bond reorganization with dynamic disulfide-bond exchange. PUHD was synthesized using polytetramethylene ether glycol (PTMEG) as the soft segment and isophorone diisocyanate (IPDI) and 4,4'-dihydroxydiphenyl disulfide (DHDPS) as hard-segment components. FT-IR, Raman, XRD, GPC, and DSC analyses confirmed the successful construction of a predominantly amorphous dual dynamic network with suitable chain mobility and thermal stability for energetic-composite applications. The neat PUHD exhibited a hardness of 0.94 MPa and a storage modulus of 3.15 MPa at 20 °C and 5 Hz; surface cracks disappeared within 24 h at ambient temperature, and the storage-modulus recovery reached approximately 97%. In sample filler-containing composites, increasing solid content enhanced hardness and modulus but restricted polymer-chain mobility, thereby slowing crack repair and reducing healing recovery. In nitrocellulose/nitroglycerin (NC/NG)-containing composites, the visible crack closure could be achieved within 24 h, while maintaining useful mechanical properties after self-healing. Notably, JQ-e showed the highest initial hardness of 2.69 MPa and retained 2.19 MPa after healing. These findings collectively demonstrate that the synergistic dynamic network not only enables efficient room-temperature crack repair but also preserves adequate mechanical reinforcement, thus offering a viable pathway toward more reliable energetic-composite formulations.

PMID 43029896
阅读全文 →
PubMedJournal of medical case reports2026-11-14

Etoposide-induced angina in a patient with small cell lung carcinoma: a case report.

Otsuka Shinya S, Chiba Yasuyuki Y, Otsuka Kenta K, Shimazu Kyo K et al.

The combination of cisplatin and etoposide is a standard therapy for small cell lung cancer; however, ischemic heart disease is a known complication. We report a rare case of effort angina pectoris that worsened during initial treatment of small cell lung cancer with etoposide. A 73-year-old Asian male was admitted to our hospital with effort angina. Coronary angiography revealed severe stenosis with significant calcification of the proximal right coronary artery. Computed tomography revealed a 21-mm-sized nodule in the right upper lobe and hilar lymphadenopathy suggestive of lung cancer. The patient underwent thoracoscopic wedge resection before coronary revascularization, and intraoperative findings indicated a small cell carcinoma with hilar lymph node metastases. Early postoperative definitive treatment consisting of chemotherapy with cisplatin plus etoposide and accelerated hyperfractionated radiation was planned. During the first chemotherapy session, on postoperative day 7, the patient complained of chest pain, and an electrocardiogram showed slight ST depression in leads V5 and V6 while receiving etoposide; nitroglycerin improved his symptoms. Although treatment was resumed with the administration of nicorandil the next day, the same symptoms were observed during the infusion of etoposide. Accordingly, chemoradiation therapy was suspended and revascularization of the right coronary artery was performed. Etoposide and cisplatin were readministered 3 days after revascularization, without any chest symptoms. Chemotherapy for malignant tumors carries the risk of progression to coronary artery disease. To prevent serious ischemic events, sufficient discussions between oncologists and cardiologists and careful observation of chest symptoms are needed.

PMID 43026561
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多nitroglycerin